Khalid Muhammad
Khalid Muhammad
Associate Professor-Immunology, United Arab Emirates University, UAE
Verified email at - Homepage
Cited by
Cited by
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
M Luu, Z Riester, A Baldrich, N Reichardt, S Yuille, A Busetti, M Klein, ...
Nature communications 12 (1), 4077, 2021
Nanotechnology: A revolution in modern industry
S Malik, K Muhammad, Y Waheed
Molecules 28 (2), 661, 2023
Focus: skin: current developments in the immunology of psoriasis
F Grän, A Kerstan, E Serfling, M Goebeler, K Muhammad
The Yale journal of biology and medicine 93 (1), 97, 2020
NFATc1 controls the cytotoxicity of CD8+ T cells
S Klein-Hessling, K Muhammad, M Klein, T Pusch, R Rudolf, J Flöter, ...
Nature communications 8 (1), 511, 2017
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
J Pieper, J Herrath, S Raghavan, K Muhammad, R Vollenhoven, ...
BMC immunology 14, 1-9, 2013
In vivo effects of the anti–interleukin‐6 receptor inhibitor tocilizumab on the B cell compartment
P Roll, K Muhammad, M Schumann, S Kleinert, H Einsele, T Dörner, ...
Arthritis & Rheumatism 63 (5), 1255-1264, 2011
Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19
HH Ellah N , Gad S , Muhammad K, Batiha G
Nanomedicine, 2020
CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis
Z Mahmood, K Muhammad, M Schmalzing, P Roll, T Dörner, HP Tony
Arthritis research & therapy 17, 1-11, 2015
NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
H Alrefai, K Muhammad, R Rudolf, DAT Pham, S Klein-Hessling, AK Patra, ...
Nature communications 7 (1), 11724, 2016
NFATc1 induction in peripheral T and B lymphocytes
M Hock, M Vaeth, R Rudolf, AK Patra, DAT Pham, K Muhammad, T Pusch, ...
The Journal of Immunology 190 (5), 2345-2353, 2013
Current insights into immunology and novel therapeutics of atopic dermatitis
HA Kader, M Azeem, SA Jwayed, A Al-Shehhi, A Tabassum, MA Ayoub, ...
Cells 10 (6), 1392, 2021
Hidden role of gut microbiome dysbiosis in schizophrenia: Antipsychotics or psychobiotics as therapeutics?
N Munawar, K Ahsan, K Muhammad, A Ahmad, MA Anwar, I Shah, ...
International journal of molecular sciences 22 (14), 7671, 2021
Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory …
K Muhammad, P Roll, T Seibold, S Kleinert, H Einsele, T Dörner, HP Tony
Annals of the rheumatic diseases 70 (8), 1507-1510, 2011
Delayed acquisition of somatic hypermutations in repopulated IGD+ CD27+ memory B cell receptors after rituximab treatment
K Muhammad, P Roll, H Einsele, T Dörner, HP Tony
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
Multiepitope subunit vaccine design against COVID-19 based on the spike protein of SARS-CoV-2: an in silico analysis
HA Dar, Y Waheed, MH Najmi, S Ismail, HF Hetta, A Ali, K Muhammad
Journal of immunology research 2020, 2020
Designing a multi-epitope vaccine against Mycobacteroides abscessus by pangenome-reverse vaccinology
HA Dar, S Ismail, Y Waheed, S Ahmad, Z Jamil, H Aziz, HF Hetta, ...
Scientific reports 11 (1), 11197, 2021
Emerging applications of nanotechnology in healthcare and medicine
S Malik, K Muhammad, Y Waheed
Molecules 28 (18), 6624, 2023
Architecture and Expression of the Nfatc1 Gene in Lymphocytes
R Rudolf, R Busch, AK Patra, K Muhammad, A Avots, JC Andrau, ...
Frontiers in immunology 5, 21, 2014
T cells control chemokine secretion by keratinocytes
T Rauschenberger, V Schmitt, M Azeem, S Klein-Hessling, K Murti, F Grän, ...
Frontiers in immunology 10, 1917, 2019
E Batiha, G.; Hetta, HF Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19
NH Abd Ellah, SF Gad, K Muhammad
Nanomedicine 15 (21), 2085-2102, 2020
The system can't perform the operation now. Try again later.
Articles 1–20